The editor-in-chief of The Lancet, Daniel, had some dealings with Chen Cang.
Although their relationship wasn't very close, they did have some interactions.
After carefully reading the paper, he became deeply intrigued by the "Chen's Elephant Trunk Stent Material."
There were no illustrations in the paper, but his curiosity was overwhelming!
This kind of new material and new surgical approach could effectively lower the mortality rate for aortic dissection and showed remarkable effectiveness for Marfan syndrome.
And!
More importantly, none of these were the key point.
The most significant element was actually in the clinical trial analysis: Chen Cang's inclusion criteria were... essentially non-existent!
This...
Expanding the inclusion criteria unrestrictedly?
Such boldness!
Thinking of this, Daniel picked up the paper and hurriedly headed to Chief Editor Prandos.
"Chief Editor, take a look at this article!"
